302 related articles for article (PubMed ID: 23408289)
21. Epigenetic Regulation of Autophagy in Cardiovascular Pathobiology.
Bu S; Singh KK
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207151
[TBL] [Abstract][Full Text] [Related]
22. Editorial: From the Editor-in-Chief.
Kang YJ
Cardiovasc Toxicol; 2021 Jan; 21(1):1. PubMed ID: 33387251
[No Abstract] [Full Text] [Related]
23. The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases.
Li J; Gao Y; Ren X; Li Y; Wu L; Yang X; Wang J; Shang H; Xiong X; Xing Y
Curr Pharm Des; 2017; 23(7):1060-1069. PubMed ID: 27774897
[TBL] [Abstract][Full Text] [Related]
24. Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity.
Petibone DM; Majeed W; Casciano DA
J Appl Toxicol; 2017 Jan; 37(1):23-37. PubMed ID: 27682190
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Autophagy in Cardiovascular Diseases by Natural Products.
Gu S; Li X
Adv Exp Med Biol; 2020; 1207():731-736. PubMed ID: 32671790
[TBL] [Abstract][Full Text] [Related]
26. Organs-on-chip models for cardiovascular drug development.
Zimmermann WH
Cardiovasc Res; 2021 Nov; 117(12):e164-e165. PubMed ID: 34347045
[No Abstract] [Full Text] [Related]
27. Angiotensin II- and Alzheimer-Type Cardiovascular Aging.
Cooper HA; Scalia R; Rizzo V; Eguchi S
Circ Res; 2018 Aug; 123(6):651-653. PubMed ID: 30355238
[TBL] [Abstract][Full Text] [Related]
28. Regulation of autophagy by some natural products as a potential therapeutic strategy for cardiovascular disorders.
Hashemzaei M; Entezari Heravi R; Rezaee R; Roohbakhsh A; Karimi G
Eur J Pharmacol; 2017 May; 802():44-51. PubMed ID: 28238768
[TBL] [Abstract][Full Text] [Related]
29. Caloric restriction mimetics for the treatment of cardiovascular diseases.
Sciarretta S; Forte M; Castoldi F; Frati G; Versaci F; Sadoshima J; Kroemer G; Maiuri MC
Cardiovasc Res; 2021 May; 117(6):1434-1449. PubMed ID: 33098415
[TBL] [Abstract][Full Text] [Related]
30. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target.
Zhou H; Li N; Yuan Y; Jin YG; Guo H; Deng W; Tang QZ
Basic Res Cardiol; 2018 Aug; 113(5):37. PubMed ID: 30094473
[TBL] [Abstract][Full Text] [Related]
31. Interfaces of psychopharmacology and cardiology--Part two.
Risch SC; Groom GP; Janowsky DS
J Clin Psychiatry; 1981 Feb; 42(2):47-59. PubMed ID: 6109718
[TBL] [Abstract][Full Text] [Related]
32. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics.
Marzetti E; Csiszar A; Dutta D; Balagopal G; Calvani R; Leeuwenburgh C
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H459-76. PubMed ID: 23748424
[TBL] [Abstract][Full Text] [Related]
33. Autophagy in cardiovascular diseases: role of noncoding RNAs.
Gao J; Chen X; Shan C; Wang Y; Li P; Shao K
Mol Ther Nucleic Acids; 2021 Mar; 23():101-118. PubMed ID: 33335796
[TBL] [Abstract][Full Text] [Related]
34. Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease.
Prieto-DomÃnguez N; Garcia-Mediavilla MV; Sanchez-Campos S; Mauriz JL; Gonzalez-Gallego J
Curr Med Chem; 2018; 25(7):814-838. PubMed ID: 28925866
[TBL] [Abstract][Full Text] [Related]
35. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.
Balgi AD; Fonseca BD; Donohue E; Tsang TC; Lajoie P; Proud CG; Nabi IR; Roberge M
PLoS One; 2009 Sep; 4(9):e7124. PubMed ID: 19771169
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular receptors as drug targets. Eur omega Conferences' Cardiovascular receptors as drug targets. Institut Pasteur, Paris, France, 3-4 October 1996.
Maack T
Mol Med Today; 1997 Mar; 3(3):101-2. PubMed ID: 9095483
[No Abstract] [Full Text] [Related]
37. Electrically-Induced Ventricular Fibrillation Alters Cardiovascular Function and Expression of Apoptotic and Autophagic Proteins in Rat Hearts.
Czegledi A; Tosaki A; Gyongyosi A; Zilinyi R; Tosaki A; Lekli I
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30986903
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
39. Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease?
Kleschyov AL; Sen' VD
Future Med Chem; 2013 Mar; 5(4):385-8. PubMed ID: 23495686
[No Abstract] [Full Text] [Related]
40. Pharmacological modulation of autophagy during cardiac stress.
Sciarretta S; Zhai P; Volpe M; Sadoshima J
J Cardiovasc Pharmacol; 2012 Sep; 60(3):235-41. PubMed ID: 22710813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
